<p>(A) Layout of microplate. Wells marked in green are CXCR4 inhibitors. Controls are shown in white: column 10 shows data for CXCR4-eGFP and CXCR4-TagRFP transfected cells without inhibitor treatment; column 11 shows CXCR4-eGFP only cells without inhibitor treatment. In column 10 the concentration of CXCL12 is varied: row D is untreated while rows E and F are treated with 5 nM and 20 nM CXCL12 respectively. (B) Comparison of anisotropy and lifetime data showing that dimerisation and internalisation is blocked by CXCR4 inhibitors. Errors bars represent the standard deviation of repeated measurements in each well (4 images per well for each modality). (C) Plots of anisotropy and FRET efficiency for column 10, rows D, E and F: cells in the ab...
IC50values for sibling cultures derived from patient tumor CC0514 treated with a panel of small mole...
<p><b>(A), (B), (C) and (D):</b> Correlation between the IC<sub>50</sub> value of the compounds for ...
During the last two decades, kinase inhibitors have become the major drug class for targeted cancer ...
The chemokine receptor CXCR4 is activated by its unique chemokine ligand CXCL12 and regulates many p...
<p>(A) A schematic illustration of a microliter-scale high-throughput screening system for three sam...
<p>A) HeyA8-CXCR4-CBRN/Ar-CBC cells were plated as two-dimensional cultures in 96 well plates and in...
The chemokine receptor CXCR4 is activated by its unique chemokine ligand CXCL12 and regulates many p...
<p>(A) Graphs illustrating cell count assay data, determined from the treatment of PC3 cells (left p...
Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...
Abstract: Seven transmembrane (7TM) G-protein-coupled receptor (GPCR) families are important targets...
Pharmacological targeting of G protein-coupled receptors (GPCRs) is of great importance to human hea...
<p>(a) 2D PCA plot of phenotype profiles for negative control (DMSO) and 12 active compounds at diff...
2013-07-30Chemokine receptor, CXCR2, and its ligands are an essential component of the immune system...
<p>The IC<sub>50</sub> values are given in nM. Values and errors (SE) shown are representative of n ...
<p>Controls are boxed in the upper-left corner and include blanks (Column 1, negative control), MU11...
IC50values for sibling cultures derived from patient tumor CC0514 treated with a panel of small mole...
<p><b>(A), (B), (C) and (D):</b> Correlation between the IC<sub>50</sub> value of the compounds for ...
During the last two decades, kinase inhibitors have become the major drug class for targeted cancer ...
The chemokine receptor CXCR4 is activated by its unique chemokine ligand CXCL12 and regulates many p...
<p>(A) A schematic illustration of a microliter-scale high-throughput screening system for three sam...
<p>A) HeyA8-CXCR4-CBRN/Ar-CBC cells were plated as two-dimensional cultures in 96 well plates and in...
The chemokine receptor CXCR4 is activated by its unique chemokine ligand CXCL12 and regulates many p...
<p>(A) Graphs illustrating cell count assay data, determined from the treatment of PC3 cells (left p...
Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...
Abstract: Seven transmembrane (7TM) G-protein-coupled receptor (GPCR) families are important targets...
Pharmacological targeting of G protein-coupled receptors (GPCRs) is of great importance to human hea...
<p>(a) 2D PCA plot of phenotype profiles for negative control (DMSO) and 12 active compounds at diff...
2013-07-30Chemokine receptor, CXCR2, and its ligands are an essential component of the immune system...
<p>The IC<sub>50</sub> values are given in nM. Values and errors (SE) shown are representative of n ...
<p>Controls are boxed in the upper-left corner and include blanks (Column 1, negative control), MU11...
IC50values for sibling cultures derived from patient tumor CC0514 treated with a panel of small mole...
<p><b>(A), (B), (C) and (D):</b> Correlation between the IC<sub>50</sub> value of the compounds for ...
During the last two decades, kinase inhibitors have become the major drug class for targeted cancer ...